WEIFANG, Shandong Province, China, May 19 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) (“Shengtai Pharmaceutical” or “the Company”), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today announced that the Company’s management will present at two upcoming investor conferences, including the Brean Murray, Carret & Co. All-Cap All-China Conference in New York City and the Roth China Discovery Tour in China.
Brean Murray, Carret & Co. All-Cap, All-China Conference
Date: Monday, May 19, 2008
Time: 1:15 p.m. EST Time
Venue: Jade Room, the Waldorf Astoria, New York City
This conference will feature formal presentations and one-on-one meetings with over 100 Chinese companies. Interested parties and investors may find more information by contacting the BMC Conference Coordinator, Barbara Bradley at (212) 702-6616 or Barbara.Bradley@bmur.com
Roth China Discovery Tour
Date: Tuesday, May 20, 2008
Time: 8:00 a.m. China Time
Venue: Hotel Regent, Beijing, China
The Roth China Discovery Tour will bring together executives from more than 60 companies in 7 cities throughout China. The event will combine factory visits with management presentations in a mini-conference format. Interested parties and institutional investors may find more information by e-mailing conference@roth.com and referencing ROTH China Discovery Tour 2008.
About Shengtai Pharmaceutical, Inc.
Shengtai Pharmaceutical, Inc. through its wholly-owned subsidiary Shengtai Holding, Inc. (SHI), a New Jersey corporation, and the Chinese operating company of Weifang Shengtai Pharmaceutical Co., Ltd., is a leading manufacturer and supplier of glucose products, which include pharmaceutical grade glucose used for medical purposes, and glucose and cornstarch products for the food and beverage industry and for industrial production in China. For more information about Shengtai Pharmaceutical, Inc. please visit http://www.shengtaipharmaceutical.com .
For more information, please contact:
Company Contact:
Ms. Melody Shi
CFO
Shengtai Pharmaceutical, Inc.
Tel: +1-949-468-7078
Email: shengtaicfo@hotmail.com
Investor Relations Contact:
Mr. Crocker Coulson
President
CCG Elite Investor Relations
Tel: +1-646-213-1915 (NY Office)
Email: crocker.coulson@ccgir.com
Web: http://www.ccgelite.com
